Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 2;12(9):3250.
doi: 10.3390/jcm12093250.

Insomnia and Death Anxiety: A Theoretical Model with Therapeutic Implications

Affiliations
Editorial

Insomnia and Death Anxiety: A Theoretical Model with Therapeutic Implications

Nathaniel F Watson. J Clin Med. .

Abstract

Insomnia is common, growing in prevalence [...].

PubMed Disclaimer

Conflict of interest statement

The author is solely responsible for the content of this publication and declares that he has served as an advisory consultant for Eisai, Jazz Pharmaceuticals, Harmony Biosciences, Takeda, Johnson and Johnson, Itamar, GlaxoSmithKline, Idorsia, Pfizer and Bayer.

Figures

Figure 1
Figure 1
Theoretical model of how death anxiety may foster development of insomnia. The impact of death anxiety on the subconscious likely fosters insomnia. Death anxiety fosters loud ego orientations. Both the quiet and loud ego can allay death anxiety. However, quieting the ego results in positive cognitive behavioral effects such as mindfulness, humility, reduced self-focus and acceptance that can mitigate or hinder insomnia. Loud ego protectionism, increased self-focus, and increased self-importance can mitigate death anxiety but also trigger or foster insomnia. Each ego orientation (e.g., loud or quiet) can undermine the psychological protection afforded by the other. Thus, the specific ego orientation used to address death anxiety may either hinder or foster insomnia development (note: arrows with “+” labels foster the behavior they point toward, while arrows with a “−“ label hinder the behavior they point toward).

References

    1. Dopheide J.A. Insomnia overview: Epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy. Am. J. Manag. Care. 2020;26((Suppl. S4)):S76–S84. doi: 10.37765/ajmc.2020.42769. - DOI - PubMed
    1. Bjorvatn B., Jernelöv S., Pallesen S. Insomnia—A Heterogenic Disorder Often Comorbid with Psychological and Somatic Disorders and Diseases: A Narrative Review with Focus on Diagnostic and Treatment Challenges. Front. Psychol. 2021;12:639198. doi: 10.3389/fpsyg.2021.639198. - DOI - PMC - PubMed
    1. Morin C.M., Benca R. Chronic insomnia. Lancet. 2012;379:1129–1141. doi: 10.1016/S0140-6736(11)60750-2. - DOI - PubMed
    1. Wickwire E.M., Shaya F.T., Scharf S.M. Health economics of insomnia treatments: The return on investment for a good night’s sleep. Sleep Med. Rev. 2016;30:72–82. doi: 10.1016/j.smrv.2015.11.004. - DOI - PubMed
    1. Akram U., Barclay N., Milkins B., Stevenson J., Gardani M. Sleep-related attentional and interpretive-bias in insomnia: A systematic review and meta-analysis. Sleep Med. Rev. 2023;67:101713. doi: 10.1016/j.smrv.2022.101713. - DOI - PubMed

Publication types

LinkOut - more resources